310 related articles for article (PubMed ID: 28791793)
1. Early transition from insulin to sulfonylureas in neonatal diabetes and follow-up: Experience from China.
Li X; Xu A; Sheng H; Ting TH; Mao X; Huang X; Jiang M; Cheng J; Liu L
Pediatr Diabetes; 2018 Mar; 19(2):251-258. PubMed ID: 28791793
[TBL] [Abstract][Full Text] [Related]
2. Molecular and clinical features of K
Hashimoto Y; Dateki S; Hirose M; Satomura K; Sawada H; Mizuno H; Sugihara S; Maruyama K; Urakami T; Sugawara H; Shirai K; Yorifuji T
Pediatr Diabetes; 2017 Nov; 18(7):532-539. PubMed ID: 27681997
[TBL] [Abstract][Full Text] [Related]
3. Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of K
Ngoc CTB; Dien TM; De Franco E; Ellard S; Houghton JAL; Lan NN; Thao BP; Khanh NN; Flanagan SE; Craig ME; Dung VC
Front Endocrinol (Lausanne); 2021; 12():727083. PubMed ID: 34566892
[TBL] [Abstract][Full Text] [Related]
4. Sulfonylurea in the treatment of neonatal diabetes mellitus children with heterogeneous genetic backgrounds.
Zhang M; Chen X; Shen S; Li T; Chen L; Hu M; Cao L; Cheng R; Zhao Z; Luo F
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):877-84. PubMed ID: 25781672
[TBL] [Abstract][Full Text] [Related]
5. Personalized precision medicine in extreme preterm infants with transient neonatal diabetes mellitus.
Kylat RI; Senguttuvan R; Bader MY
J Pediatr Endocrinol Metab; 2017 May; 30(5):593-596. PubMed ID: 28350539
[TBL] [Abstract][Full Text] [Related]
6. Clinical and genetic features of Argentinian children with diabetes-onset before 12months of age: Successful transfer from insulin to oral sulfonylurea.
Taberner P; Flanagan SE; Mackay DJ; Ellard S; Taverna MJ; Ferraro M
Diabetes Res Clin Pract; 2016 Jul; 117():104-10. PubMed ID: 27329029
[TBL] [Abstract][Full Text] [Related]
7. Case report: Better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants.
Mancioppi V; Pozzi E; Zanetta S; Missineo A; Savastio S; Barbetti F; Mellone S; Giordano M; Rabbone I
Front Endocrinol (Lausanne); 2023; 14():1143736. PubMed ID: 37251668
[TBL] [Abstract][Full Text] [Related]
8. Personalized medicine switching from insulin to sulfonylurea in permanent neonatal diabetes mellitus dictated by a novel activating ABCC8 mutation.
Mak CM; Lee CY; Lam CW; Siu WK; Hung VC; Chan AY
Diagn Mol Pathol; 2012 Mar; 21(1):56-9. PubMed ID: 22306677
[TBL] [Abstract][Full Text] [Related]
9. Transient neonatal diabetes with two novel mutations in the KCNJ11 gene and response to sulfonylurea treatment in a preterm infant.
Siklar Z; Ellard S; Okulu E; Berberoğlu M; Young E; Savaş Erdeve S; Mungan IA; Hacihamdioğlu B; Erdeve O; Arsan S; Oçal G
J Pediatr Endocrinol Metab; 2011; 24(11-12):1077-80. PubMed ID: 22308870
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.
Bowman P; Sulen Å; Barbetti F; Beltrand J; Svalastoga P; Codner E; Tessmann EH; Juliusson PB; Skrivarhaug T; Pearson ER; Flanagan SE; Babiker T; Thomas NJ; Shepherd MH; Ellard S; Klimes I; Szopa M; Polak M; Iafusco D; Hattersley AT; Njølstad PR;
Lancet Diabetes Endocrinol; 2018 Aug; 6(8):637-646. PubMed ID: 29880308
[TBL] [Abstract][Full Text] [Related]
11. An oral sulfonylurea in the treatment of transient neonatal diabetes mellitus.
Loomba-Albrecht LA; Glaser NS; Styne DM; Bremer AA
Clin Ther; 2009 Apr; 31(4):816-20. PubMed ID: 19446154
[TBL] [Abstract][Full Text] [Related]
12. Improved long-term glucose control in neonatal diabetes mellitus after early sulfonylurea allergy.
Shah B; Breidbart E; Pawelczak M; Lam L; Kessler M; Franklin B
J Pediatr Endocrinol Metab; 2012; 25(3-4):353-6. PubMed ID: 22768668
[TBL] [Abstract][Full Text] [Related]
13. Successful sulfonylurea treatment of an insulin-naïve neonate with diabetes mellitus due to a KCNJ11 mutation.
Wambach JA; Marshall BA; Koster JC; White NH; Nichols CG
Pediatr Diabetes; 2010 Jun; 11(4):286-8. PubMed ID: 19656320
[TBL] [Abstract][Full Text] [Related]
14. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
Pearson ER; Flechtner I; Njølstad PR; Malecki MT; Flanagan SE; Larkin B; Ashcroft FM; Klimes I; Codner E; Iotova V; Slingerland AS; Shield J; Robert JJ; Holst JJ; Clark PM; Ellard S; Søvik O; Polak M; Hattersley AT;
N Engl J Med; 2006 Aug; 355(5):467-77. PubMed ID: 16885550
[TBL] [Abstract][Full Text] [Related]
15. KCNJ11 in-frame 15-bp deletion leading to glibenclamide- responsive neonatal diabetes mellitus in a Chinese child.
Yang W; Wei H; Sang Y
J Pediatr Endocrinol Metab; 2013; 26(5-6):591-4. PubMed ID: 23640936
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Molecular Characterization of Children with Neonatal Diabetes Mellitus at a Tertiary Care Center in Northern India.
Jain V; Satapathy A; Yadav J; Sharma R; Radha V; Mohan V; De Franco E; Ellard S
Indian Pediatr; 2017 Jun; 54(6):467-471. PubMed ID: 28667717
[TBL] [Abstract][Full Text] [Related]
17. Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a new KCNJ11 mutation.
Ješić MM; Ješić MD; Maglajlić S; Sajić S; Necić S
Diabetes Res Clin Pract; 2011 Jan; 91(1):e1-3. PubMed ID: 21056492
[TBL] [Abstract][Full Text] [Related]
18. Long-term Follow-up of Glycemic and Neurological Outcomes in an International Series of Patients With Sulfonylurea-Treated
Bowman P; Mathews F; Barbetti F; Shepherd MH; Sanchez J; Piccini B; Beltrand J; Letourneau-Freiberg LR; Polak M; Greeley SAW; Rawlins E; Babiker T; Thomas NJ; De Franco E; Ellard S; Flanagan SE; Hattersley AT;
Diabetes Care; 2021 Jan; 44(1):35-42. PubMed ID: 33184150
[TBL] [Abstract][Full Text] [Related]
19. KCNJ11 in-frame 15-bp deletion leading to glibenclamide-responsive neonatal diabetes mellitus in a Chinese child.
Yang W; Wei H; Sang Y
J Pediatr Endocrinol Metab; 2013; 26(7-8):743-6. PubMed ID: 24266052
[TBL] [Abstract][Full Text] [Related]
20. Emergence of insulin resistance following empirical glibenclamide therapy: a case report of neonatal diabetes with a recessive INS gene mutation.
Yildiz M; Akcay T; Aydin B; Akgun A; Dogan BB; De Franco E; Ellard S; Onal H
J Pediatr Endocrinol Metab; 2018 Mar; 31(3):345-348. PubMed ID: 29305569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
